ClinicalTrials.Veeva

Menu
L

Lake Regional Health System | Lake Regional Hospital - Cancer Center

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Paclitaxel
Carboplatin
Cisplatin
Pemetrexed Disodium
Nab-paclitaxel
Docetaxel
Gemcitabine Hydrochloride
Pemetrexed
Etoposide
Relugolix

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 31 total trials

Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1)

A Phase 2 multi-center open-label basket trial of nab-sirolimus for adult and adolescent patients with malignant solid tumors harboring pathogenic in...

Active, not recruiting
Solid Tumor
Malignant Neoplasm
Drug: nab-sirolimus

This was a randomized study to evaluate the risk of major adverse cardiovascular events (MACE) for relugolix compared with leuprolide acetate. Enroll...

Active, not recruiting
Prostate Cancer
Drug: Leuprolide Acetate
Drug: Relugolix

This phase II trial studies how well vismodegib, focal adhesion kinase (FAK) inhibitor GSK2256098, and capivasertib work in treating patients with me...

Enrolling
Recurrent Meningioma
NF2 Gene Mutation
Drug: Abemaciclib
Drug: Vismodegib

Trial sponsors

Alliance for Clinical Trials in Oncology logo
ECOG-ACRIN Cancer Research Group logo
National Cancer Institute (NCI) logo
NRG Oncology logo
SWOG Cancer Research Network logo
A
C
Mass General Brigham logo
Sumitomo Pharma logo
Tempus AI logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems